Literature DB >> 19841175

In vitro responses to avian influenza H5 by human CD4 T cells.

Matthew F Cusick1, Shuping Wang, David D Eckels.   

Abstract

To address the question of whether human T cells are capable of recognizing novel isolates of influenza virus, in vitro responses to recombinant Ags and synthetic peptides derived from the sequences of H1, H3, and H5 were examined in a cohort of 64 individuals selected from a healthy blood donor population. Humans respond in vitro to H1 and H3 following exposure through natural infection and vaccination. Responses to H5 were well correlated with those to H1 or H3, and thus, a significant repertoire of H5-responsive T cells is present in many individuals; clear nonresponders to H1, H3, and H5, however, do exist. Differences were observed in the cytokine responses to H1, H3, and H5, whereas both IL-2 and IFN-gamma production characteristic of memory responses were observed for H1 and H3, and H5-specific responses elicited primarily IL-2 and little or no IFN-gamma, consistent with a naive T cell phenotype. Responses to all influenza HA were restricted by HLA-DR molecules. To address the structural basis for T cell recognition of H1 and H5, overlapping synthetic peptides were used to identify epitopes and to determine whether recognition of H5 was limited to homologous sequences in H1, the most closely related HA phylogenetically. Although responses were generally correlated, no complete structural overlap was observed. These results suggest that helper T cell cross reactivity between different influenza strains may impart cross-protection to H5N1 strain of influenza.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841175      PMCID: PMC2783553          DOI: 10.4049/jimmunol.0901617

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Host species barriers to influenza virus infections.

Authors:  Thijs Kuiken; Edward C Holmes; John McCauley; Guus F Rimmelzwaan; Catherine S Williams; Bryan T Grenfell
Journal:  Science       Date:  2006-04-21       Impact factor: 47.728

2.  Vaccines against avian influenza--a race against time.

Authors:  Gregory A Poland
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

3.  Bird flu not set for pandemic, says US team.

Authors:  Erika Check
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

4.  H5N1 influenza--continuing evolution and spread.

Authors:  Robert G Webster; Elena A Govorkova
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

5.  Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

Authors:  Chung-Lam Cheung; Jane M Rayner; Gavin J D Smith; Pui Wang; T S P Naipospos; Jinxia Zhang; Kwok-Yung Yuen; Robert G Webster; J S Malik Peiris; Yi Guan; Honglin Chen
Journal:  J Infect Dis       Date:  2006-05-09       Impact factor: 5.226

6.  Migratory birds and avian flu.

Authors:  Rob Fergus; Michael Fry; William B Karesh; Peter P Marra; Scott Newman; Ellen Paul
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

7.  Large-scale sequence analysis of avian influenza isolates.

Authors:  John C Obenauer; Jackie Denson; Perdeep K Mehta; Xiaoping Su; Suraj Mukatira; David B Finkelstein; Xiequn Xu; Jinhua Wang; Jing Ma; Yiping Fan; Karen M Rakestraw; Robert G Webster; Erich Hoffmann; Scott Krauss; Jie Zheng; Ziwei Zhang; Clayton W Naeve
Journal:  Science       Date:  2006-01-26       Impact factor: 47.728

8.  Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

Authors:  Jean-Louis Bresson; Christian Perronne; Odile Launay; Catherine Gerdil; Melanie Saville; John Wood; Katja Höschler; Maria C Zambon
Journal:  Lancet       Date:  2006-05-20       Impact factor: 79.321

9.  Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.

Authors:  Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

10.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.

Authors:  Shinya Yamada; Yasuo Suzuki; Takashi Suzuki; Mai Q Le; Chairul A Nidom; Yuko Sakai-Tagawa; Yukiko Muramoto; Mutsumi Ito; Maki Kiso; Taisuke Horimoto; Kyoko Shinya; Toshihiko Sawada; Makoto Kiso; Taiichi Usui; Takeomi Murata; Yipu Lin; Alan Hay; Lesley F Haire; David J Stevens; Rupert J Russell; Steven J Gamblin; John J Skehel; Yoshihiro Kawaoka
Journal:  Nature       Date:  2006-11-16       Impact factor: 49.962

View more
  17 in total

1.  Detection of site-specific positive Darwinian selection on pandemic influenza A/H1N1 virus genome: integrative approaches.

Authors:  Ramaiah Arunachalam
Journal:  Genetica       Date:  2013-03-26       Impact factor: 1.082

2.  Ebolavirus evolves in human to minimize the detection by immune cells by accumulating adaptive mutations.

Authors:  Arunachalam Ramaiah; Vaithilingaraja Arumugaswami
Journal:  Virusdisease       Date:  2016-02-22

3.  Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.

Authors:  Brian C Schanen; Anne S De Groot; L Moise; Matt Ardito; Elizabeth McClaine; William Martin; Vaughan Wittman; William L Warren; Donald R Drake
Journal:  Vaccine       Date:  2011-02-22       Impact factor: 3.641

4.  Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.

Authors:  Chiara Agrati; Cristiana Gioia; Concetta Castilletti; Daniele Lapa; Giulia Berno; Vincenzo Puro; Fabrizio Carletti; Eleonora Cimini; Carla Nisii; Flora Castellino; Federico Martini; Maria R Capobianchi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-08       Impact factor: 2.205

5.  Highly conserved hemagglutinin peptides of H1N1 influenza virus elicit immune response.

Authors:  Neha Lohia; Manoj Baranwal
Journal:  3 Biotech       Date:  2018-11-20       Impact factor: 2.406

Review 6.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 7.  Hallmarks of CD4 T cell immunity against influenza.

Authors:  K K McKinstry; T M Strutt; S L Swain
Journal:  J Intern Med       Date:  2011-03-25       Impact factor: 8.989

8.  Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity.

Authors:  Anthony DiPiazza; Katherine Richards; Nicholas Poulton; Andrea J Sant
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

9.  A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.

Authors:  Jenny Aurielle B Babon; John Cruz; Francis A Ennis; Liusong Yin; Masanori Terajima
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

10.  In vitro antigen-specific induction of IL-22 in human subjects that resolved HCV infection.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami; David D Eckels
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.